CTC Alternative Strategies »

Lineage Cell Therapeutics In shares owned by CTC Alternative Strategies

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by CTC Alternative Strategies from 13F filings

Historical chart of CTC Alternative Strategies investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by CTC Alternative Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by CTC Alternative Strategies

Quarter filed Position value Share count Share price at filing
2026-03-31 $24k 15k 1.58

More positions owned by CTC Alternative Strategies

Select Sector Spdr Tr State Street Com (XLC)
Coinbase Global Com Cl A (COIN)
Arm Holdings Sponsored Ads (ARM)
Broadcom (AVGO)
Select Sector Spdr Tr State Street Con (XLY)
NVIDIA Corporation (NVDA)
Technipfmc (FTI)
AFLAC Incorporated (AFL)
Medline Com Cl A (MDLN)
Autodesk (ADSK)
Tesla Motors (TSLA)
Wal-Mart Stores (WMT)
AutoZone (AZO)
Coreweave Com Cl A (CRWV)
Chime Finl Com Shs Cl A (CHYM)

View all positions for CTC Alternative Strategies

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
Vanguard Group
Vanguard Capital Management
Defender Capital
Millennium Management
Raffles Associates
Fifth Third Bancorp
Brian McDonald
BlackRock
Armistice Capital
Geode Capital Management
Renaissance Technologies
Morgan Stanley
UBS Group
Marshall Wace

View all funds holding Lineage Cell Therapeutics In